Literature DB >> 21453569

SOGC–GOC–SCC Joint Policy Statement. No. 255, March 2011. Cervical cancer prevention in low-resource settings.

Laurie Elit1, Waldo Jimenez, Jessica McAlpine, Prafull Ghatage, Dianne Miller, Marie Plante.   

Abstract

OBJECTIVE: To help care providers understand the current status of cervical cancer in low-resource countries. OPTIONS: The most effective and practical options for cervical screening and treatment in low-resource countries are evaluated. OUTCOMES: Improvement in rates of prevention and early detection of cervical cancer in low-resource countries. EVIDENCE: PubMed or Medline, CINAHL, and The Cochrane Library were searched for studies published in English between January 2006 and December 2009. Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology assessment-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. VALUES: The quality of evidence was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care. Recommendations for practice were ranked according to the method described in that report (Table). RECOMMENDATIONS 1. All girls 9 years old or over should have access to the cervical cancer vaccine before they become sexually active. (I-A) 2. Cervical cancer screening by visual inspection with acetic acid is suggested for low-resource settings acceptable. Cervical cytology or human papillomavirus testing may also be used when practical. (II-2B) 3. Cryotherapy is a safe, effective, and low-cost therapy that should be included in pre-invasive cervical cancer treatment. (III-B) 4. All countries should have a documented cervical cancer prevention strategy that includes public education built on existing outreach programs. (III-C) 5. Countries should define a centre or centres of excellence for the management of cervical cancer. (III-C) Because these units would serve a larger population, they would be able to identify leaders and develop their skills, and would be able to invest in costly radiation equipment. 6. All women with cervical cancer should have access to pain management. (III-C).

Entities:  

Mesh:

Year:  2011        PMID: 21453569     DOI: 10.1016/s1701-2163(16)34830-7

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  6 in total

1.  Knowledge, Awareness and Prevention of Cervical Cancer among Women Attending a Tertiary Care Hospital in Puducherry, India.

Authors:  Jansirani Siddharthar; Bhuvaneshwari Rajkumar; Kuberan Deivasigamani
Journal:  J Clin Diagn Res       Date:  2014-06-20

2.  Cervical cancer screening through human papillomavirus testing in community health campaigns versus health facilities in rural western Kenya.

Authors:  Megan J Huchko; Saduma Ibrahim; Cinthia Blat; Craig R Cohen; Jennifer S Smith; Robert A Hiatt; Elizabeth Bukusi
Journal:  Int J Gynaecol Obstet       Date:  2018-01-03       Impact factor: 3.561

Review 3.  Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries.

Authors:  Margaret M Demment; Karen Peters; J Andrew Dykens; Ann Dozier; Haq Nawaz; Scott McIntosh; Jennifer S Smith; Angela Sy; Tracy Irwin; Thomas T Fogg; Mahmooda Khaliq; Rachel Blumenfeld; Mehran Massoudi; Timothy De Ver Dye
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

4.  Feasibility of thermocoagulation in a screen-and-treat approach for the treatment of cervical precancerous lesions in sub-Saharan Africa.

Authors:  Manuela Viviano; Bruno Kenfack; Rosa Catarino; Eveline Tincho; Liliane Temogne; Anne-Caroline Benski; Pierre-Marie Tebeu; Ulrike Meyer-Hamme; Pierre Vassilakos; Patrick Petignat
Journal:  BMC Womens Health       Date:  2017-01-07       Impact factor: 2.809

Review 5.  Human papillomavirus vaccination in low-resource countries: lack of evidence to support vaccinating sexually active women.

Authors:  V Tsu; M Murray; S Franceschi
Journal:  Br J Cancer       Date:  2012-09-06       Impact factor: 7.640

6.  Disparities in cervical cancer screening participation in Iran: a cross-sectional analysis of the 2016 nationwide STEPS survey.

Authors:  Rozhin Amin; Ali-Asghar Kolahi; Nader Jahanmehr; Ali-Reza Abadi; Mohammad-Reza Sohrabi
Journal:  BMC Public Health       Date:  2020-10-22       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.